Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00175084 · ClinicalTrials.gov registry record · NA

Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers

A NA study of Cardiovascular Diseases and Hyperlipidemias, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00175084: Completed NA study of Cardiovascular Diseases and Hyperlipidemias, sponsored by Tufts University.

NCT00175084 is a NA study of Cardiovascular Diseases and Hyperlipidemias that has completed, run by Tufts University. The registered enrollment target is 30 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00175084, a NA study of Cardiovascular Diseases and Hyperlipidemias, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to explore the significance of the Lys:Arg ratio on responses of lipids and lipoprotein concentrations to dietary proteins and to evaluate the effects of dietary Lys:Arg on cardiovascular disease risk factors and endothelial function.

Interventions

  • BEHAVIORAL Comparison of dietary protein amino acid profile

Study Locations (1)

Massachusetts

  • Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2004-10
Est. Completion 2012-12
Phase NA
Tufts University

163 total trials

What the finished NCT00175084 record still lists

NCT00175084 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Comparison of dietary protein amino acid profile is the first listed.

NCT00175084 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00175084 about?

NCT00175084 is a clinical study titled "Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers". The aim of this study is to explore the significance of the Lys:Arg ratio on responses of lipids and lipoprotein concentrations to dietary proteins and to evaluate the effects of dietary Lys:Arg on cardiovascular disease risk factors and endothelial function.

What is the current status of trial NCT00175084?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2004-10. Estimated completion is 2012-12.

What conditions does trial NCT00175084 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Hyperlipidemias, Metabolic Syndrome X.

What interventions are being tested in trial NCT00175084?

The interventions under investigation include: Comparison of dietary protein amino acid profile (BEHAVIORAL).

Who is sponsoring clinical trial NCT00175084?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00175084 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00175084's enrollment target sits among peer trials

30 262nd of 300 higher than 33 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00175084, the US trial registry maintained by the National Library of Medicine. NCT00175084 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.